June 2021

Prasugrel vs. ticagrelor for PCI patients | The dangers of Southern-style diets | Abbott gains key approvals ()
June in Review: iPhones interfere with cardiac devices | Think before you eat | Valve-in-valve TAVR outcomes ()
Big news for new-look diabetes drug tirzepatide | Cardiologist makes history | AMI outcomes during the pandemic ()
The most common reasons for hospitalization in the US | HCM & AFib ()
Economics & Policy: The physician shortage is coming | ‘A victory for people with serious illnesses’ | Beverage taxes work ()
Week in Review: High-risk HF patients | AFIb & alcohol | A historic FDA approval | Insulin syringes recalled ()
Low heart rate reported in elderly COVID-19 patient | The latest on vaccine-related heart damage | Statin therapy & cancer ()
Heart Failure: Disease progression in asymptomatic patients | Vaccine-related heart damage resolves in days ()
FDA approves first oral blood thinner for pediatric patients | New metric IDs high-risk HF patients | Think before you eat ()
STEMI patients with aortic stenosis | Medtronic's big approval | Valve-in-valve TAVR outcomes ‘excellent’ after 1 year ()
Structural Heart Disease: Newer heart valves & aortic angulation | TMVR for AMI patients | LAAO during cardiac surgery ()
Statin therapy not associated with dementia | Smiths Medical recalls insulin syringes | Tai chi helps stroke survivors ()
Vaccine-related heart damage resolves within days | Alcohol & AFib | Disease progression among stable HF patients ()
Week in Review: The future of wearable tech | The top hospitals for pediatric cardiology | Cell therapy for HF ()
Healthcare orgs praise Supreme Court decision | Beverage taxes work | New data on cancer & AFib ()
Financial struggles common among CVD patients | AI-powered ECGs help detect COVID-19 | TEER with MitraClip XTR ()
Practice Management: The incoming physician shortage | A new path forward | TAVR or surgery? ()
The top 10 hospitals for pediatric cardiology | The approaching physician shortage | TAVR during the pandemic ()
Prevention & Risk Reduction: Lowering the risk of severe COVID symptoms | Plant-based meals & CVD ()
AFib patients missing out on the care they need | How AI & cardiac imaging can help predict heart attacks ()
Is this the future of wearable tech? | Aortic angulation & TAVR | Heart health & COVID outcomes ()
Week in Review: TMVR after AMI | Recovering from COVID-19 | Additional benefits of a healthy diet ()
TMVR among heart attack patients | New data on clonal hematopoiesis & CV health | Abbott announces key approvals ()
Athletes recovering from COVID-19 with no long-term heart damage | Comorbid conditions & TAVR outcomes ()
Vascular & Endovascular: COVID-19 surges & stroke care | LAAO lowers the risk of stroke after surgery ()
Heart Rhythm: A warning about fish oil supplements | Long-term monitoring detects unsuspected AFib ()
Week in Review: Medtronic pulls HVAD system from market | A big recall in Canada | iPhones & implantable devices ()
COVID surges & patient care | Medtronic stops sales & distribution of HVAD system | LAAO during cardiac surgery ()
Breaking News: Medtronic stops sales & distribution of HVAD system due to multiple issues ()
The latest data on iPhones interfering with implantable devices | TAVR vs. SAVR for low-gradient AS ()
Interventional & Surgery: PCI among cancer patients | Revascularization for complex CAD | Radial vs. femoral access ()
Acute Coronary Syndromes: Aggressive BP management | CVD deaths are down, but many counties still struggle ()
More than 200 lots of irbesartan, losartan & valsartan recalled | PCI vs. CABG for elderly patients | New LAAC data ()